BioMedNewsBreaks – MediXall Group Inc. (MDXL) Launches New Telehealth Solutions for Uninsured, Underinsured

MediXall Group (OTCQB: MDXL), a technology and innovation-driven organization focused on reducing costs of health care and transforming the patient-provider experience through the launch of its Health Karma(TM) platform, today announced new virtual-care solutions for the uninsured and underinsured. Effective immediately, Americans can conduct an online medical visit with a board-certified medical professional to get fast and easy treatment, prescriptions and lab tests for routine medical issues. This new service is a result of Health Karma’s recent partnership with leading telehealth company MeMD. “Telehealth will continue to be a popular option for patients, providers and employers beyond the pandemic,” Health Karma President Michael Swartz said in the news release. “It is a privilege for Health Karma to provide affordable virtual care for our users to ensure they get the care they need at a price that is accessible.”

Click here to view the full press release.

About MediXall Group Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for health care without intruding on the important relationship with trusted doctors. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective health care for the consumer. By approaching the health-care ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. For more information, visit www.MediXallGroup.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights,…

12 hours ago

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that its wholly owned subsidiary HOPE…

14 hours ago

BioMedNewsBreaks — HealthLynked Corp. (OTCQB: HLYK) Completes Reverse Stock Split to Support Growth Plans

HealthLynked (OTCQB: HLYK) has completed a reverse stock split as part of its strategy to…

4 days ago

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Publishes Data Demonstrating Two-Year Stability of ThermoVax Ebolavirus Vaccines

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced the publication of…

4 days ago

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Preclinical Data Showing CNM-Au8 Improves Cellular Health in Parkinson’s Disease Model 

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc., announced new preclinical data…

4 days ago

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Highlights CEO Dr. Vuong Trieu’s Impact and Clinical Pipeline Progress

Oncotelic Therapeutics (OTCQB: OTLC), a clinical-stage biopharmaceutical company developing oncology and immunotherapy treatments, provided an…

5 days ago